Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$86.5 - $128.27 $853,668 - $1.27 Million
-9,869 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$101.96 - $128.34 $43,129 - $54,287
-423 Reduced 4.11%
9,869 $1.16 Million
Q4 2021

Jan 19, 2022

SELL
$106.37 - $130.68 $762,566 - $936,844
-7,169 Reduced 41.06%
10,292 $1.33 Million
Q3 2021

Oct 05, 2021

BUY
$102.91 - $122.75 $4,528 - $5,401
44 Added 0.25%
17,461 $1.98 Million
Q2 2021

Jul 12, 2021

SELL
$83.84 - $104.76 $299,392 - $374,097
-3,571 Reduced 17.01%
17,417 $1.8 Million
Q1 2021

Apr 22, 2021

SELL
$78.68 - $90.67 $151,773 - $174,902
-1,929 Reduced 8.42%
20,988 $1.76 Million
Q4 2020

Jan 25, 2021

BUY
$71.69 - $91.23 $204,459 - $260,187
2,852 Added 14.21%
22,917 $2.09 Million
Q3 2020

Oct 16, 2020

BUY
$67.19 - $87.44 $378,615 - $492,724
5,635 Added 39.05%
20,065 $1.6 Million
Q2 2020

Jul 08, 2020

BUY
$57.54 - $76.95 $547,665 - $732,410
9,518 Added 193.77%
14,430 $997,000
Q1 2020

Apr 07, 2020

BUY
$52.41 - $81.0 $96,696 - $149,445
1,845 Added 60.16%
4,912 $927,000
Q4 2019

Jan 07, 2020

SELL
$71.7 - $82.09 $8,819 - $10,097
-123 Reduced 3.86%
3,067 $716,000
Q3 2019

Nov 06, 2019

SELL
$61.55 - $75.43 $2,277 - $2,790
-37 Reduced 1.15%
3,190 $702,000
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $1,783 - $2,061
32 Added 1.0%
3,227 $596,000
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $11,277 - $13,836
-243 Reduced 7.07%
3,195 $489,000
Q3 2018

Nov 07, 2018

SELL
$45.7 - $58.03 $27,237 - $34,585
-596 Reduced 14.77%
3,438 $599,000
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $24,408 - $29,497
-575 Reduced 12.48%
4,034 $587,000
Q1 2018

May 10, 2018

SELL
$37.19 - $47.45 $22,983 - $29,324
-618 Reduced 11.82%
4,609 $643,000
Q4 2017

Feb 07, 2018

BUY
$33.79 - $39.39 $4,527 - $5,278
134 Added 2.63%
5,227 $647,000
Q3 2017

Nov 07, 2017

BUY
$36.29 - $38.83 $184,824 - $197,761
5,093
5,093 $612,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.